BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1174 related articles for article (PubMed ID: 21419767)

  • 1. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
    Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
    Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression.
    Liu HP; Cao AT; Feng T; Li Q; Zhang W; Yao S; Dann SM; Elson CO; Cong Y
    Eur J Immunol; 2015 Apr; 45(4):1010-8. PubMed ID: 25605286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
    Feng T; Qin H; Wang L; Benveniste EN; Elson CO; Cong Y
    J Immunol; 2011 Jun; 186(11):6313-8. PubMed ID: 21531892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice.
    Liu B; Tonkonogy SL; Sartor RB
    Gastroenterology; 2011 Aug; 141(2):653-62, 662.e1-4. PubMed ID: 21679711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
    Shao TY; Hsu LH; Chien CH; Chiang BL
    Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stat4 is critical for the balance between Th17 cells and regulatory T cells in colitis.
    Xu J; Yang Y; Qiu G; Lal G; Yin N; Wu Z; Bromberg JS; Ding Y
    J Immunol; 2011 Jun; 186(11):6597-606. PubMed ID: 21525389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoted Generation of T Helper 1-Like Regulatory T Cells After Transient Middle Cerebral Artery Occlusion in Type-2 Diabetic Mice.
    Jian L; Hu Y; Gao M; Shu L
    Immunol Invest; 2023 Nov; 52(4):482-498. PubMed ID: 37076315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells' Differentiation and Function in Induction of Colitis.
    Chen L; Sun M; Wu W; Yang W; Huang X; Xiao Y; Ma C; Xu L; Yao S; Liu Z; Cong Y
    Inflamm Bowel Dis; 2019 Aug; 25(9):1450-1461. PubMed ID: 30918945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in mice.
    Ono Y; Kanai T; Sujino T; Nemoto Y; Kanai Y; Mikami Y; Hayashi A; Matsumoto A; Takaishi H; Ogata H; Matsuoka K; Hisamatsu T; Watanabe M; Hibi T
    Gastroenterology; 2012 Nov; 143(5):1288-1297. PubMed ID: 22850180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ induces expression of MHC class II on intestinal epithelial cells and protects mice from colitis.
    Thelemann C; Eren RO; Coutaz M; Brasseit J; Bouzourene H; Rosa M; Duval A; Lavanchy C; Mack V; Mueller C; Reith W; Acha-Orbea H
    PLoS One; 2014; 9(1):e86844. PubMed ID: 24489792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis.
    Yang J; Xu L
    Med Sci Monit; 2016 Aug; 22():2785-92. PubMed ID: 27498708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice.
    Liao G; Detre C; Berger SB; Engel P; de Waal Malefyt R; Herzog RW; Bhan AK; Terhorst C
    Gastroenterology; 2012 Mar; 142(3):582-591.e8. PubMed ID: 22155173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Expression of IL-17A in Foxp3 Fate-Tracked Cells in
    Bittner-Eddy PD; Fischer LA; Costalonga M
    Front Immunol; 2020; 11():677. PubMed ID: 32391008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.
    Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T
    Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.
    Huber S; Gagliani N; Esplugues E; O'Connor W; Huber FJ; Chaudhry A; Kamanaka M; Kobayashi Y; Booth CJ; Rudensky AY; Roncarolo MG; Battaglia M; Flavell RA
    Immunity; 2011 Apr; 34(4):554-65. PubMed ID: 21511184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.